Global Bipolar Disorder Market

- Size, Trend, Share, Opportunity Analysis & Forecast, 2014-2025

  • Date Healthcare
  • Date July 2017
  • price $3619
 
 

Bipolar disorder or manic-depressive illness, is a brain disorder that causes unusual shifts in mood and activity levels such as periods of depression and elevated mood which is known as mania or hypomania. In addition, this disorder is differentiated as manic episodes and depressive episodes. The patients suffering from bipolar disorders experience serious shifts in mood, energy, and thinking. The disorders involve periods of mania at one point (such as have racing thoughts, have lots of energy), to the lows of depression at the other (such as feeling of sadness or apathy). The global bipolar disorder market is expected to grow at a CAGR of 3.2% from 2017 to 2025.

Based on drug class, the global bipolar disorder market is segmented as mood stabilizers, anticonvulsants, atypical antipsychotics, antidepressant drugs, and anti-anxiety drugs. Based on mechanism of action, it is classified as selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, Monoamine oxidase inhibitors, benzodiazepines, beta blockers, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Market Dynamics

Drivers

  • Rise in number of bipolar disorders cases.
  • Growth in public awareness about infertility.
  • Technological advancements in bipolar disorder treatment.

Restraints

  • Stringent regulations and adverse drug reactions of anticonvulsants.
  • Unapproved bipolar drugs.

Market Players

The top players in the global bipolar disorder market include Otsuka, Pfizer, Janssen pharmaceuticals, Ferrer, Allergan, Abbott Laboratories Inc., Bristol-Myers Squibb Company, AstraZeneca PLC, Cephalon Inc., Eli Lilly and Company, Dainippon Sumitomo Pharma Co. Ltd., Forest Laboratories Inc., GlaxoSmithKline PLC, Gedeon Richter PLC, H. Lundbeck A/S, Merck & Co., Inc., and others.

KEY TAKEAWAY

Bipolar Disorder Market

MARKET LANDSCAPE

By Drug Class

  • Mood stabilizers
  • Anticonvulsants
  • Atypical antipsychotics
  • Antidepressant drugs
  • Anti-anxiety drugs

By Mechanism of Action

  • Selective serotonin reuptake inhibitors
  • Serotonin-norepinephrine reuptake inhibitors
  • Tricyclic antidepressants
  • Monoamine oxidase inhibitors
  • Benzodiazepines
  • Beta blockers
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
1. Executive summary
1.1. Key Findings
1.2. Market Attractiveness and Trend analysis
1.3. Competitive Landscape and recent industry development analysis
2. Introduction
2.1. Report Description
2.2. Scope and Definitions
2.3. Research Methodology
3. Market landscape
3.1. Growth Drivers
3.1.1. Impact Analysis
3.2. Restrains and Challenges
3.2.1. Impact Analysis
3.3. Porter’s Analysis
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Industry rivalry
3.3.5. Threat of new entrants
3.4. Global Bipolar Disorder Market Shares Analysis, 2014-2025
3.4.1. Global Bipolar Disorder Market by Drug Class, 2014-2025
3.4.2. Global Bipolar Disorder Market by Mechanism of Action, 2014-2025
3.4.3. Global Bipolar Disorder Market by Geography, 2014-2025
4. Global Bipolar Disorder Market by Drug class
4.1. Mood stabilizers
4.1.1. Historical Market Size by Region, 2014-2016
4.1.2. Market Forecast by Region, 2017-2025
4.2. Anticonvulsants
4.2.1. Historical Market Size by Region, 2014-2016
4.2.2. Market Forecast by Region, 2017-2025
4.3. Atypical antipsychotics
4.3.1. Historical Market Size by Region, 2014-2016
4.3.2. Market Forecast by Region, 2017-2025
4.4. Antidepressant drugs
4.4.1. Historical Market Size by Region, 2014-2016
4.4.2. Market Forecast by Region, 2017-2025
4.5. Anti-anxiety drugs
4.5.1. Historical Market Size by Region, 2014-2016
4.5.2. Market Forecast by Region, 2017-2025
5. Global Bipolar Disorder Market by Mechanism of Action
5.1. Selective serotonin reuptake inhibitors
5.1.1. Historical Market Size by Region, 2014-2016
5.1.2. Market Forecast by Region, 2017-2025
5.2. Serotonin-norepinephrine reuptake inhibitors
5.2.1. Historical Market Size by Region, 2014-2016
5.2.2. Market Forecast by Region, 2017-2025
5.3. Tricyclic antidepressants
5.3.1. Historical Market Size by Region, 2014-2016
5.3.2. Market Forecast by Region, 2017-2025
5.4. Monoamine oxidase inhibitors
5.4.1. Historical Market Size by Region, 2014-2016
5.4.2. Market Forecast by Region, 2017-2025
5.5. Benzodiazepines
5.5.1. Historical Market Size by Region, 2014-2016
5.5.2. Market Forecast by Region, 2017-2025
5.6. Beta blockers
5.6.1. Historical Market Size by Region, 2014-2016
5.6.2. Market Forecast by Region, 2017-2025
5.7. Others
5.7.1. Historical Market Size by Region, 2014-2016
5.7.2. Market Forecast by Region, 2017-2026
6. Global Bipolar Disorder Market by Geography
6.1. North America
6.1.1. U.S.
6.1.1.1. Historical Market Size, 2014-2016
6.1.1.2. Market Forecast, 2017-2025
6.1.2. Canada
6.1.2.1. Historical Market Size, 2014-2016
6.1.2.2. Market Forecast, 2017-2025
6.1.3. Mexico
6.1.3.1. Historical Market Size, 2014-2016
6.1.3.2. Market Forecast, 2017-2025
6.2. Europe
6.2.1. UK
6.2.1.1. Historical Market Size, 2014-2016
6.2.1.2. Market Forecast, 2017-2025
6.2.2. Germany
6.2.2.1. Historical Market Size, 2014-2016
6.2.2.2. Market Forecast, 2017-2025
6.2.3. France
6.2.3.1. Historical Market Size, 2014-2016
6.2.3.2. Market Forecast, 2017-2025
6.2.4. Spain
6.2.4.1. Historical Market Size, 2014-2016
6.2.4.2. Market Forecast, 2017-2025
6.2.5. Italy
6.2.5.1. Historical Market Size, 2014-2016
6.2.5.2. Market Forecast, 2017-2025
6.2.6. Rest of Europe
6.2.6.1. Historical Market Size, 2014-2016
6.2.6.2. Market Forecast, 2017-2025
6.3. Asia-Pacific
6.3.1. China
6.3.1.1. Historical Market Size, 2014-2016
6.3.1.2. Market Forecast, 2017-2025
6.3.2. Japan
6.3.2.1. Historical Market Size, 2014-2016
6.3.2.2. Market Forecast, 2017-2025
6.3.3. India
6.3.3.1. Historical Market Size, 2014-2016
6.3.3.2. Market Forecast, 2017-2025
6.3.4. Australia
6.3.4.1. Historical Market Size, 2014-2016
6.3.4.2. Market Forecast, 2017-2025
6.3.5. South Korea
6.3.5.1. Historical Market Size, 2014-2016
6.3.5.2. Market Forecast, 2017-2025
6.3.6. Rest of Asia-Pacific
6.3.6.1. Historical Market Size, 2014-2016
6.3.6.2. Market Forecast, 2017-2025
6.4. LAMEA
6.4.1. Brazil
6.4.1.1. Historical Market Size, 2014-2016
6.4.1.2. Market Forecast, 2017-2025
6.4.2. Saudi Arabia
6.4.2.1. Historical Market Size, 2014-2016
6.4.2.2. Market Forecast, 2017-2025
6.4.3. South Africa
6.4.3.1. Historical Market Size, 2014-2016
6.4.3.2. Market Forecast, 2017-2025
6.4.4. Rest of LAMEA
6.4.4.1. Historical Market Size, 2014-2016
6.4.4.2. Market Forecast, 2017-2025
7. Company profiles
7.1. Otsuka
7.1.1. Overview
7.1.2. Financials and business segments
7.1.3. Recent developments
7.2. Pfizer
7.2.1. Overview
7.2.2. Financials and business segments
7.2.3. Recent developments
7.3. Janssen pharmaceuticals
7.3.1. Overview
7.3.2. Financials and business segments
7.3.3. Recent developments
7.4. Eli Lilly
7.4.1. Overview
7.4.2. Financials and business segments
7.4.3. Recent developments
7.5. Ferrer
7.5.1. Overview
7.5.2. Financials and business segments
7.5.3. Recent developments
7.6. Allergan
7.6.1. Overview
7.6.2. Financials and business segments
7.6.3. Recent developments
7.7. Abbott Laboratories Inc
7.7.1. Overview
7.7.2. Financials and business segments
7.7.3. Recent developments
7.8. Bristol-Myers Squibb Company
7.8.1. Overview
7.8.2. Financials and business segments
7.8.3. Recent developments
7.9. AstraZeneca PLC.
7.9.1. Overview
7.9.2. Financials and business segments
7.9.3. Recent developments
7.10. GlaxoSmithKline PLC
7.10.1. Overview
7.10.2. Financials and business segments
7.10.3. Recent developments

List of Tables

Table 1. Bipolar Disorder Market Value, by Drug class, 2014-2025, $million
Table 2. Bipolar Disorder Market Value, by Mechanism of action, 2014-2025, $million
Table 3. Bipolar Disorder Market Value, by Region, 2014-2025, $million
Table 4. Bipolar Disorder Market Value for Mood stabilizers, by Region, 2017-2025, $million
Table 5. Bipolar Disorder Market Value for Anticonvulsants, by Region, 2017-2025, $million
Table 6. Bipolar Disorder Market Value for Atypical Antipsychotics, by Region, 2017-2025, $million
Table 7. Bipolar Disorder Market Value for Antidepressant Drugs, by Region, 2017-2025, $million
Table 8. Bipolar Disorder Market Value for Anti-anxiety Drugs, by Region, 2017-2025, $million
Table 9. Bipolar Disorder Market Value for Selective Serotonin Reuptake Inhibitors, by Region, 2017-2025, $million
Table 10. Bipolar Disorder Market Value for Serotonin-norepinephrine Reuptake Inhibitors, by Region, 2017-2025, $million
Table 11. Bipolar Disorder Market Value for Tricyclic Antidepressants, by Region, 2017-2025, $million
Table 12. Bipolar Disorder Market Value for Monoamine Oxidase Inhibitors, by Region, 2017-2025, $million
Table 13. Bipolar Disorder Market Value for Benzodiazepines, by Region, 2017-2025, $million
Table 14. Bipolar Disorder Market Value for Beta Blockers, by Region, 2017-2025, $million
Table 15. Bipolar Disorder Market Value for Others, by Region, 2017-2025, $million
Table 16. Bipolar Disorder Market Value for North America, by Country, 2014-2025, $million
Table 17. Bipolar Disorder Market Value for North America, by Drug Class, 2014-2025, $million
Table 18. Bipolar Disorder Market Value for North America, by Mechanism of Action, 2014-2025, $million
Table 19. Bipolar Disorder Market Value for Europe, by Country, 2014-2025, $million
Table 20. Bipolar Disorder Market Value for Europe, by Drug Class, 2014-2025, $million
Table 21. Bipolar Disorder Market Value for Europe, by Mechanism of Action, 2014-2025, $million
Table 22. Bipolar Disorder Market Value for Asia-Pacific, by Country, 2014-2025, $million
Table 23. Bipolar Disorder Market Value for Asia-Pacific, by Drug Class, 2014-2025, $million
Table 24. Bipolar Disorder Market Value for Asia-Pacific, by Mechanism of Action, 2014-2025, $million
Table 25. Bipolar Disorder Market Value for LAMEA, by Country, 2014-2025, $million
Table 26. Bipolar Disorder Market Value for LAMEA, by Drug Class, 2014-2025, $million
Table 27. Bipolar Disorder Market Value for LAMEA, by Mechanism of Action, 2014-2025, $million
Table 28. Otsuka - Company Snapshot
Table 29. Pfizer - Company Snapshot
Table 30. Janssen pharmaceuticals - Company Snapshot
Table 31. Eli Lilly - Company Snapshot
Table 32. Ferrer - Company Snapshot
Table 33. Allergan - Company Snapshot
Table 34. Abbott Laboratories Inc. - Company Snapshot
Table 35. Bristol-Myers Squibb Company - Company Snapshot
Table 36. AstraZeneca PLC - Company Snapshot
Table 37. GlaxoSmithKline PLC - Company Snapshot

List of Figures

Figure 1. Bipolar Disorder: Mood stabilizers Market Value, 2014-2016, $million
Figure 2. Bipolar Disorder: Anticonvulsants Market Value, 2014-2016, $million
Figure 3. Bipolar Disorder: Atypical Antipsychotics Market Value, 2014-2016, $million
Figure 4. Bipolar Disorder: Antidepressant Drugs Market Value, 2014-2016, $million
Figure 5. Bipolar Disorder: Anti-anxiety Drugs Market Value, 2014-2016, $million
Figure 6. Bipolar Disorder: Selective Serotonin Reuptake Inhibitors Market Value, 2014-2016, $million
Figure 7. Bipolar Disorder: Serotonin-norepinephrine Reuptake Inhibitors Market Value, 2014-2016, $million
Figure 8. Bipolar Disorder: Tricyclic Antidepressants Market Value, 2014-2016, $million
Figure 9. Bipolar Disorder: Monoamine Oxidase Inhibitors Market Value, 2014-2016, $million
Figure 10. Bipolar Disorder: Benzodiazepines Market Value, 2014-2016, $million
Figure 11. Bipolar Disorder: Beta blockers Market Value, 2014-2016, $million
Figure 12. Bipolar Disorder: Others Market Value, 2014-2016, $million
Figure 13. Bipolar Disorder: U.S. Market Value, 2014-2016, $million
Figure 14. Bipolar Disorder: U.S. Market Value, 2017-2025, $million
Figure 15. Bipolar Disorder: Canada Market Value, 2014-2016, $million
Figure 16. Bipolar Disorder: Canada Market Value, 2017-2025, $million
Figure 17. Bipolar Disorder: Mexico Market Value, 2014-2016, $million
Figure 18. Bipolar Disorder: Mexico Market Value, 2017-2025, $million
Figure 19. Bipolar Disorder: UK Market Value, 2014-2016, $million
Figure 20. Bipolar Disorder: UK Market Value, 2017-2025, $million
Figure 21. Bipolar Disorder: Germany Market Value, 2014-2016, $million
Figure 22. Bipolar Disorder: Germany Market Value, 2017-2025, $million
Figure 23. Bipolar Disorder: France Market Value, 2014-2016, $million
Figure 24. Bipolar Disorder: France Market Value, 2017-2025, $million
Figure 25. Bipolar Disorder: Spain Market Value, 2014-2016, $million
Figure 26. Bipolar Disorder: Spain Market Value, 2017-2025, $million
Figure 27. Bipolar Disorder: Italy Market Value, 2014-2016, $million
Figure 28. Bipolar Disorder: Italy Market Value, 2017-2025, $million
Figure 29. Bipolar Disorder: Rest of Europe Market Value, 2014-2016, $million
Figure 30. Bipolar Disorder: Rest of Europe Market Value, 2017-2025, $million
Figure 31. Bipolar Disorder: China Market Value, 2014-2016, $million
Figure 32. Bipolar Disorder: China Market Value, 2017-2025, $million
Figure 33. Bipolar Disorder: Japan Market Value, 2014-2016, $million
Figure 34. Bipolar Disorder: Japan Market Value, 2017-2025, $million
Figure 35. Bipolar Disorder: India Market Value, 2014-2016, $million
Figure 36. Bipolar Disorder: India Market Value, 2017-2025, $million
Figure 37. Bipolar Disorder: Australia Market Value, 2014-2016, $million
Figure 38. Bipolar Disorder: Australia Market Value, 2017-2025, $million
Figure 39. Bipolar Disorder: South Korea Market Value, 2014-2016, $million
Figure 40. Bipolar Disorder: South Korea Market Value, 2017-2025, $million
Figure 41. Bipolar Disorder: Rest of Asia-Pacific Market Value, 2014-2016, $million
Figure 42. Bipolar Disorder: Rest of Asia-Pacific Market Value, 2017-2025, $million
Figure 43. Bipolar Disorder: Brazil Market Value, 2014-2016, $million
Figure 44. Bipolar Disorder: Brazil Market Value, 2017-2025, $million
Figure 45. Bipolar Disorder: Saudi Arabia Market Value, 2014-2016, $million
Figure 46. Bipolar Disorder: Saudi Arabia Market Value, 2017-2025, $million
Figure 47. Bipolar Disorder: South Africa Market Value, 2014-2016, $million
Figure 48. Bipolar Disorder: South Africa Market Value, 2017-2025, $million
Figure 49. Bipolar Disorder: Rest of LAMEA Market Value, 2014-2016, $million
Figure 50. Bipolar Disorder: Rest of LAMEA Market Value, 2017-2025, $million
License Type
Single User PDF
Enterprise Online /PDF
Price
User / Sharing
Restricted to one authorized user
Unlimited within company / enterprise
Printing
One Print only
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS

20% Free customization (Pre-sale)

16 Analyst hour support (Post Sale)

40 Analyst hour support (Post Sale)

160 hours of mini-consult

Free quarterly industry update

Free report on update (within 180 days)

MULTIPLE PURCHASE

Complimentary report with 2 reports

Complimentary report with 3 reports

Subscription Model

 
 

Similar Market Research Report

blog
Sep
2017
Global In Vitro Fertilization (IVF) Services Market

In vitro fertilization (IVF) is an artificial fertilization process that is performed in the laboratory under artificial environment. The colloquial term for babies conceived through the IVF procedures is test-tube ... Read More >>

 

Get Email Alert